Table 3 Distribution of changes in perceived risk from baseline to follow-up, stratified by cancer, genetic result, and follow-up time
Breast | Prostate | Colorectal | Lung | |||||
|---|---|---|---|---|---|---|---|---|
Genetic risk result | Average | Elevated | Average | Elevated | Average | Elevated | Average | Elevated |
2-week follow-up | ||||||||
Frequency, n (%) | 514 (89.2) | 62 (10.8) | 278 (78.5) | 76 (21.5) | 728 (75.1) | 241 (24.9) | 781 (80.8) | 185 (19.2) |
Unit change in perceived risk (%) | ||||||||
−4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 |
−3 | 0.6 | 0.0 | 1.4 | 0.0 | 0.7 | 0.4 | 0.5 | 0.0 |
−2 | 6.8 | 6.5 | 5.0 | 1.3 | 3.6 | 0.8 | 2.7 | 1.6 |
−1 | 23.7 | 6.5 | 26.6 | 14.5 | 22.7 | 11.6 | 19.1 | 11.4 |
0 | 51.6 | 37.1 | 51.1 | 25.0 | 50.0 | 38.2 | 47.0 | 37.3 |
+ 1 | 14.0 | 35.5 | 14.0 | 35.5 | 19.2 | 35.7 | 24.2 | 31.9 |
+ 2 | 3.3 | 14.5 | 1.4 | 14.5 | 3.7 | 9.5 | 5.9 | 12.4 |
+ 3 | 0.0 | 6.5 | 0.4 | 7.9 | 0.0 | 3.7 | 0.5 | 5.4 |
+ 4 | 0.0 | 0.0 | 0.0 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 |
6-month follow-up | ||||||||
Frequency, n (%) | 511 (90.4) | 54 (9.6) | 266 (77.6) | 77 (22.4) | 717 (75.7) | 230 (24.3) | 773 (81.8) | 172 (18.2) |
Unit change in perceived risk (%) | ||||||||
−4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
−3 | 0.6 | 1.9 | 0.8 | 0.0 | 0.1 | 0.0 | 0.7 | 0.0 |
−2 | 6.7 | 0.0 | 4.9 | 5.2 | 4.6 | 1.7 | 2.7 | 1.7 |
−1 | 23.1 | 18.5 | 26.3 | 10.4 | 21.5 | 15.7 | 18.4 | 12.8 |
0 | 50.9 | 33.3 | 51.5 | 32.5 | 52.4 | 40.9 | 48.0 | 41.3 |
+1 | 13.9 | 27.8 | 14.7 | 33.8 | 16.9 | 30.0 | 22.9 | 27.9 |
+2 | 4.5 | 13.0 | 1.9 | 10.4 | 4.2 | 9.6 | 6.3 | 10.5 |
+3 | 0.4 | 1.9 | 0.0 | 5.2 | 0.1 | 2.2 | 0.8 | 5.8 |
+4 | 0.0 | 3.7 | 0.0 | 2.6 | 0.1 | 0.0 | 0.1 | 0.0 |